Everest Biotech/Uric Acid Assay Kit 100 assays/1200061002/100 assays,Everest Biotech,,Everest Biotech,everestbiotech,+,,Array.Array.Array蚂蚁淘厂家直采.

产品名称：Everest Biotech/Uric Acid Assay Kit 100 assays/1200061002/100 assays

产品编号：1200061002

市场价：¥1487.20

场地：美国(厂家直采)

产品分类：试剂盒>其它试剂盒>其它检测试剂盒>

联系QQ：1570468124

电话号码：4000-520-616

邮箱： info@ebiomall.com

美元价：$143.00

品牌： Everest Biotech

公司：Everest Biotech

公司分类：

商品介绍

SampleTyple	Plasma,Serum,Cellculturesupernatant,otherbodyfluid
Components
Method	Colorimetricmethodat570nm
StandardCurve
Sensitivity	10µM-500µM
ReactionTime	30minutes
Applications	ForBIOLOGicalresearch: UricAcidmeasurementinbiologicalsamples Fordrug/pharmresearch: Druginfluenceonpurinemetabolism
Storage	-80°C
Notes	Materialneededbutnotsupplied Aplatereadercapableofmeasuringabsorbanceat570nm AdjustablePipettesandarepeatpipettor Thedistilledwater(milliQorHPLC-grade) ClearFlatbottom96-wellplatesifnotincludedinthekitpurchased
Shipping	Icepacks

ReagentPreparation

Note:Allreagentsarefrozen.Werecommendyouspinsmallvialsbeforeopening.

1.UricAcidAssayBuffer(10x)
PleasedonotdiluteintheprovidedUricAcidAssayBufferbottleitself.
Thebottlecontains10mlof10xUricAcidAssayBuffer.TheAssayBuffermustbeequilibratedtoroomtemperaturebeforeuse.Pleasemakeappropriateamountof1xUricAcidAssayBufferfortheassay,forexample,bydiluting1mlof10xUricAcidAssayBufferwith9mlofdH2O.Preparetheadditionaldilutedassaybufferifneeded.Storeat-80?C.

2.UricAcidStandard(2x)

PleasedonotdiluteintheprovidedUricAcidStandardvialitself.

Thevialcontains500µlof1mMUricAcidStandard.Thestandardmustbeequilibratedtoroomtemperaturebeforeuse.Dilute500µlof1mMUricAcidStandardwith500µlofdilutedUricAcidAssaybuffertoprepare500µMofUricAcidStandard.1mlof500µMUricAcidStandardisenoughformaking3standardcurvesifassayedinduplicate.Storeat-80?C.

3.AssayProbe
Thevialcontains45μlofAssayProbe.Itissufficientfor100wells.Theassayprobemustbeequilibratedtoroomtemperaturebeforeuse.Protectfromlight.Storeat-80?C.

4.UricAcidAssayEnzymeMix
Thevialcontains30μlofUricAcidAssayEnzymeMix.Theenzymemixmustbethawedonicebeforeuse.Itissufficientfor100wells.Storeat-80?C.

Protocol

1.SamplePreparation

Blood(serum/plasma),urine,otherbodyfluidscanbemeasureddirectlybyaseriesofdilutionsofthesample(1/2;1/4;1/8;…)toensurethereADIngsarewithinthestandardcurverange.YoursamplescanbedilutedwithdH2OordilutedUricAcidAssayBuffer.

Add50μlofsamplestoeachwell.
Werecommendthatsamplesbeassayedinduplicateortriplicate.

Note:
Ifpreparedsamplesarenotassayedthesameday,storethesamplesat-80?C.Thesampleswillbestableforonemonthwhilestoredat-80?C.Forfrozensamples,dilutionsofsamplesmustbedonerightbeforeassaying.

2.StandardCurvePrepation

Add50μl,40μl,30μl,20μl,10μl,5μl,1μl,and0μlofdilutedUricAcidStandardtoeachwell,thenadjustvolumeto50μl/wellwithdilutedUricAcidAssayBuffer.
WerecommendthatUricAcidStandardsbeassayedinduplicate.Astandardcurvehastoberunineachassay.

3.ReactionSolutionPreparation
50μlReactionMixisrequiredforeachwelland1mlofReactionSolutionispreparedwiththefollowings:
984µlUricAcidAssayBuffer(1x)
8µlUricAcidAssayEnzymeMix
8µlAssayProbe

1mlofReactionSolutionisenoughfor~20wells.

PrepareappropriateamountofReactionSolutionforthenumberofassaystobeperformed.

Note:PleasedonotkeepanyleftoverReactionSolutionasithastobemadefreshrightbeforeyourunassays.IfoldReactionSolutionisused,assayswillnotwork.

4.Performtheassay

a.Mixthereactionsolutionwellandadd50μlofthereactionsolutiontoeachwellcontainingtheUricAcidstandardsandtestsamples.

b.Incubatethereactionfor30minutesina37?Cincubator.

c.Measureabsorbanceat570nminamicroplatereader.

5.Calculation

a.AveragetheOD570nmvaluesofreplicatewellsofeachUricAcidStandard,testsamples,andblank.Then,correctbackgroundbysubtractingthevaluederivedfromtheblankfromallsamplereadings.

b.MakeastandardcurvebyplottingOD570nmvaluesfromeachUricAcidStandardsasafunctionofUricAcidconcentration.Thiscanbedonewithexcelspreadsheet.

c.CalculatethevalueofUricAcidinsamplesusingtheequationobtainedfromthelinearregressionofthestandardcurve.

UricAcid(μM)=[(Correctedabsorbance)-(y-intercept)]/Slope

MaterialSafetyDataSheet

Date:Oct26,2015

1.PRODUCTANDCOMPANYIDENTIFICATION

1.1Productidentifier

Productname:UricAcidAssayKit

CatalogNo:1200061002,120006100P

1.2Relevantidentifiedusesofthesubstanceormixtureandusesadvisedagainst

Forresearchuseonly.

1.3Detailsofthesupplierofthesafetydatasheet

Company:EtonBioscienceInc

TollFree:1-800-758-1630

Tel:1-800-758-1630

Fax:1-800-507-2912

1.4Emergencytelephonenumber

1-800-758-1630

2.HAZARDSIDENTIFICATION

2.1Classificationofthesubstanceormixture

Notahazardoussubstanceormixture

2.2GHSLabelelements,includingprecautionarystatements

Notahazardoussubstanceormixture

2.3Otherhazards

None

3.COMPOSITION/INFORMATIONONINGREDIENTS

3.1Substances

4.FIRSTAIDMEASURES

4.1Descriptionoffirstaidmeasures

Eyecontact

Checkforandremovecontactlensesandflushwithcopiousamountsofwater;assureadequateflushingbyseparatingtheeyelidswithfingers;callaphysician

SkinContact

Flushwithcopiousamountsofwater;removecontaminatedclothingandshoes;callaphysician

Inhalation

Removetofreshair.Ifnotbreathinggiveartificialrespiration;callaphysician

Ingestion

Ifswallowed,nevergiveanythingbymouthtoanunconsciousperson.Rinsemouthwithwater;callaphysician

4.2Mostimportantsymptomsandeffects,bothacuteanddelayed

Noinformationavailable

4.3Indicationofanyimmediatemedicalattentionandspecialtreatmentneeded.

Noinformationavailable

5.FIREFIGHTINGMEASURES

5.1Extinguishingmedia

Suitableextinguishingmedia

Waterspray,alcohol-resistantfoam,drychemicalorcarbondioxide

5.2Specialhazardsarisingfromthesubstanceormixture

Noinformationavailable

5.3Adviceforfirefighters

Wearself-containedbreathingapparatusandprotectiveclothingtopreventcontactwithskinandeyes.

6.ACCIDENTALRELEASEMEASURES

6.1Personalprecautions,protectiveequipmentandemergencyprocedures

Usefullpersonalprotectiveequipment.Evacuatepersonneltosafeareas.Avoidbreathingvapors,mistorgas.

6.2Environmentalprecautions

Preventfurtherleakageorspillage.Preventproductfromenteringdrain.

6.3Methodsandmaterialforcontainmentandcleaningup

Keepinsuitable,closedcontainersfordisposal

7.HANDLINGANDSTORAGE

7.1Precautionsforsafehandling

Avoidskin/eyecontact.Useprotectiveequipmentasneeded.Washcontaminatedclothingbeforereuse.

7.2Conditionsforsafestorage,includinganyincompatibilities

Keepcontainertightlyclosed.Storeat-80?C.

7.3Specificenduse(s)

Nodataavailable.

8.EXPOSURECONTROLS/PERSONALINFORMATION

8.1ControlParameters

Thisproductcontainsnohazardousmaterialswithoccupationalexposurelimits.

8.2Exposurecontrols

Engineeringcontrols

Provideshowerandeyewashstation

Personalprotectiveequipment

UricAcidStandard		UricAcidAssayEnzymeMix
Components	CAS#	Components	CAS#
UricAcid	69-93-2	Uricase	9002-12-4
LithiumCarbonate	554-13-2	Tris-HClpH7.5	N/A
Water	7732-18-5	Water	7732-18-5
UricAcidAssayBuffer		AssayProbe
Components	CAS#	Components	CAS#
Tris-HClpH7.5	N/A	DMSO	67-68-5
Water	7732-18-5

EyeProtection	Wearsafetygoggles
SkinProtection	Wearprotectiveclothing
HandProtection	Wearprotectivegloves
Respiratoryprotection	WearNIOSH/MSHAapprovedrespirators

9.PHYSICALANDCHEMICALPROPERTIES

9.1Informationonbasicphysicalandchemicalproperties

UricAcidAssayBuffer

Appearance	Liquid,colorless
pH	7.5
Meltingpoint	Nodataavailable
Freezingpoint	Nodataavailable
Boilingpoint	Nodataavailable
Density	Nodataavailable
Watersolubility	Soluble

UricAcidStandard

Appearance	Liquid,colorless
pH	Nodataavailable
Meltingpoint	Nodataavailable
Freezingpoint	Nodataavailable
Boilingpoint	Nodataavailable
Density	Nodataavailable
Watersolubility	Soluble

UricAcidAssayEnzymeMix

Appearance	Liquid,colorless
pH	Nodataavailable
Meltingpoint	Nodataavailable
Freezingpoint	Nodataavailable
Boilingpoint	Nodataavailable
Density	Nodataavailable
Watersolubility	Soluble

AssayProbe

Appearance	Liquid,colorless
pH	Nodataavailable
Meltingpoint	Nodataavailable
Freezingpoint	Nodataavailable
Boilingpoint	Nodataavailable
Density	Nodataavailable
Watersolubility	Soluble

9.2Othersafetyinformation

Nodataavailable.

10.STABILITYANDREACTIVITY

10.1Reactivity

Nodataavailable

10.2Chemicalstability

Stableunderrecommendedstorageconditions.

10.3Possibilityofhazardousreactions

Nodataavailable.

10.4Conditionstoavoid

Nodataavailable

10.5IncompatIBLematerials

Strongoxidizingagents

10.6Hazardousdecompositionproducts

Hazardousdecompositionproductsformedunderfireconditions:carbonoxides

11.TOXICOLOGICALINFORMATION

11.1Informationontoxicologicaleffects

Toxicologicaleffectsonthisproducthavenotbeenthoroughlystudied.

12.ECOLOGICALINFORMATION

12.1Toxicity

Avoidreleaseintoenvironment

12.2Persistenceanddegradability

Nodataavailable

12.3.Bioaccumulativepotential

Nodataavailable

12.4Mobilityinsoil

Nodataavailable

12.5ResultsofPBTandvPvBassessment

Nodataavailable

12.6Otheradverseeffects

Nodataavailable

13.DISPOSALINFORMATION

13.1Wastetreatmentmethods

Disposeinaccordancewithlocal,state,andfederalregulations.

14.TRANSPORTINFORMATION

DOT:

Propershippingname:none
Non-Hazardousfortransport:thissubstanceisconsideredtobenon-hazardousfortransport
IATA:

Propershippingname:none
Non-Hazardousfortransport:thissubstanceisconsideredtobenon-hazardousfortransport

ADR/RID

Propershippingname:none
Non-Hazardousfortransport:thissubstanceisconsideredtobenon-hazardousfortransport

15.REGULATORYINFORMATION

EURiskandSafetyphrases:

R36/37/38:irritatingtoeyes/respiratorysystem/skin

16.OTHERINFORMATION

Theinformationaboveisbelievedtobeaccurateandrepresentsthebestinformationcurrentlyavailabletous.However,wemakenowarrantyofmerchantabilityoranyotherwarranty,expressorimplied,withrespecttosuchinformation.EtonBioscienceInc.shallnotbeheldliableforanydamagesorotherconsequencesresultingfromhandlingorfromcontactwiththeaboveproduct.

1.MilnerJA,PerkinsEG.,Determinationofuricacidinbiologicalfluidsbyhighperformanceliquidchromatography.AnalBiochem,88:560–5(1978).

2.PachlaLA,KissingerPT.Measurementofserumuricacidbyliquidchromatography.ClinChem,25:1847–52(1979).

3.Watanabe,S.,Kang,D.-H.,Feng,L.,etal.Uricacid,hominoidevolution,andthepathogenesisofsalt-sensitivity.Hypertension40,355-360(2002).

4.Arias-MendozaF,PiñaE.(1991).AsensitivemultienzymaticassayforthemeasurementofUricAcid,dihydroxyacetonephosphate,oxaloacetate,andacetoacetateinclearextractsfrombiologicalsamples.PrepBiochem.21(4):211-4.

5.ChariotP.etal(1994).OptimalhandlingofbloodsamplesforroutinemeasurementoflactateandUricAcid.ArchPatholLabMed.118(7):695-7.

Esquivel,CarlosJ.,BryanJ.Cassone,andPeterM.Piermarini.“AdeNovoTranscriptomeoftheMalpighianTubulesinNon-Blood-FedandBlood-FedAsianTigerMosquitoesAedesAlbopictus:InsightsintoDiuresis,Detoxification,andBloodMealProcessing.”Ed.StephenTobe.PeerJ4(2016):e1784.PMC.Web.9Aug.2017.

品牌介绍

Everest Biotech公司成立于2000年，由英国牛津大学一批生物化学家创建。公司科学家团队具有丰富的抗体纯化及蛋白组学专业知识，雄厚的专业背景赋予了公司能为全球科研人员提供高质量、创新性抗体产品的能力。目前，Everest Biotech可提供3000余种抗体，涉及肿瘤、自身免疫、过敏、心血管疾病、传染病、代谢、神经科学等领域。所有抗体均由Everest Biotech自主研发生产、全部经过肽亲和纯化以保证最佳的特异性和纯度、经过免疫原肽的ELISA和WB实验验证; 由PhD科学家团队提供全方位技术支持服务。Everest Biotech为众多国际知名抗体公司提供OEM服务。